Retirement Systems of Alabama trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 2.5% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 85,391 shares of the company’s stock after selling 2,210 shares during the period. Retirement Systems of Alabama’s holdings in Bath & Body Works were worth $4,082,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Fifth Third Bancorp raised its holdings in shares of Bath & Body Works by 1.2% in the first quarter. Fifth Third Bancorp now owns 17,493 shares of the company’s stock worth $836,000 after buying an additional 200 shares during the period. EWG Elevate Inc. increased its holdings in Bath & Body Works by 2.2% during the 4th quarter. EWG Elevate Inc. now owns 11,491 shares of the company’s stock worth $802,000 after purchasing an additional 246 shares during the period. Signaturefd LLC increased its holdings in Bath & Body Works by 72.4% during the 4th quarter. Signaturefd LLC now owns 693 shares of the company’s stock worth $48,000 after purchasing an additional 291 shares during the period. Profund Advisors LLC increased its holdings in Bath & Body Works by 5.6% during the 4th quarter. Profund Advisors LLC now owns 5,676 shares of the company’s stock worth $396,000 after purchasing an additional 300 shares during the period. Finally, GM Advisory Group Inc. increased its holdings in Bath & Body Works by 0.5% during the 4th quarter. GM Advisory Group Inc. now owns 71,120 shares of the company’s stock worth $4,963,000 after purchasing an additional 350 shares during the period. Hedge funds and other institutional investors own 97.11% of the company’s stock.
Several research analysts have commented on BBWI shares. TheStreet downgraded Bath & Body Works from a “c+” rating to a “d” rating in a report on Friday, June 3rd. Morgan Stanley reduced their price objective on Bath & Body Works from $95.00 to $64.00 and set an “overweight” rating on the stock in a report on Friday, May 20th. B. Riley reduced their price objective on Bath & Body Works from $76.00 to $67.00 and set a “buy” rating on the stock in a report on Friday, May 20th. Robert W. Baird dropped their target price on Bath & Body Works from $75.00 to $65.00 and set an “outperform” rating on the stock in a research report on Thursday, May 19th. Finally, JPMorgan Chase & Co. cut Bath & Body Works from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $63.00 to $30.00 in a research report on Wednesday, June 29th. Three investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $64.20.
In other Bath & Body Works news, CFO Wendy C. Arlin sold 6,000 shares of Bath & Body Works stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total transaction of $330,000.00. Following the completion of the sale, the chief financial officer now owns 98,888 shares of the company’s stock, valued at approximately $5,438,840. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Thomas E. Mazurek sold 16,338 shares of Bath & Body Works stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $42.25, for a total value of $690,280.50. Following the transaction, the insider now owns 11,225 shares of the company’s stock, valued at approximately $474,256.25. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.
Bath & Body Works stock opened at $26.70 on Thursday. The stock has a market capitalization of $6.11 billion, a price-to-earnings ratio of 5.82, a PEG ratio of 0.85 and a beta of 1.72. Bath & Body Works, Inc. has a 1-year low of $25.75 and a 1-year high of $82.00. The business has a fifty day moving average price of $39.29 and a 200-day moving average price of $49.48.
Bath & Body Works (NYSE:BBWI – Get Rating) last issued its quarterly earnings results on Wednesday, May 18th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.13. Bath & Body Works had a negative return on equity of 69.03% and a net margin of 15.41%. The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.43 billion. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 3.95 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, June 17th. Shareholders of record on Friday, June 3rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, June 2nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.00%. Bath & Body Works’s dividend payout ratio is currently 17.43%.
Bath & Body Works Company Profile (Get Rating)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Get Rating).
Receive News & Ratings for Bath & Body Works Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.
